SCHEMBL29964154

SCHEMBL29964154

COCCN1CCN(c2ccc(I)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.51
HSD17B10 Q99714 1/20 0.48
MAP4K1 Q92918 1/20 0.47
SIGMAR1 Q99720 4/20 0.46
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HTR1A P08908 4/20 0.43
HTR2A P28223 3/20 0.43
DRD3 P35462 2/20 0.43
TMEM97 Q5BJF2 2/20 0.43
HRH1 P35367 1/20 0.43
KCNH2 Q12809 1/20 0.42
HTR7 P34969 1/20 0.42
ADRA1A P35348 1/20 0.42
KDM4E B2RXH2 2/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TLR9 Q9NR96 1/20 0.42
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8350747 0.85 MAPT (0.58) DRD2HSD17B10SIGMAR1HTR1AHTR2A
SCHEMBL1812286 0.83 MAPT (0.62) DRD2HSD17B10SIGMAR1MEN1KMT2A
SCHEMBL19099996 0.83 DRD2 (0.73) DRD2HSD17B10SIGMAR1MEN1KMT2A
SCHEMBL24681554 0.83 KDM4E (0.60) DRD2SIGMAR1MEN1KMT2AHTR1A
SCHEMBL6151540 0.83 MAPT (0.62) DRD2HSD17B10SIGMAR1MEN1KMT2A
SCHEMBL20306340 0.82 DRD2 (0.54) DRD2HSD17B10SIGMAR1MEN1KMT2A
SCHEMBL4577059 0.81 DRD2 (0.49) DRD2HSD17B10MAP4K1SIGMAR1MEN1
SCHEMBL29816483 0.81 HTR1A (0.56) DRD2SIGMAR1HTR1AHTR2ADRD3
SCHEMBL16437255 0.81 HRH3 (0.56) DRD2HSD17B10KDM4EMAPTGFER
SCHEMBL12089874 0.81 KDM2B (0.55) DRD2HSD17B10MEN1KMT2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 DRD2 4804/4885HSD17B10 1998/4885MAP4K1 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.